Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 3
1979 2
1980 3
1983 2
1984 3
1987 1
1990 1
1991 1
1993 1
1994 1
1999 1
2000 2
2001 2
2002 1
2003 2
2004 1
2005 2
2006 5
2007 1
2008 3
2009 3
2011 1
2012 3
2013 3
2014 1
2015 1
2016 2
2017 1
2019 6
2020 4
2021 2
2022 7
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
Saad MB, Hong L, Aminu M, Vokes NI, Chen P, Salehjahromi M, Qin K, Sujit SJ, Lu X, Young E, Al-Tashi Q, Qureshi R, Wu CC, Carter BW, Lin SH, Lee PP, Gandhi S, Chang JY, Li R, Gensheimer MF, Wakelee HA, Neal JW, Lee HS, Cheng C, Velcheti V, Lou Y, Petranovic M, Rinsurongkawong W, Le X, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Antonoff MB, Sepesi B, Lewis J, Wistuba II, Hazle JD, Chung C, Jaffray D, Gibbons DL, Vaporciyan A, Lee JJ, Heymach JV, Zhang J, Wu J. Saad MB, et al. Among authors: petranovic m. Lancet Digit Health. 2023 Jul;5(7):e404-e420. doi: 10.1016/S2589-7500(23)00082-1. Epub 2023 May 31. Lancet Digit Health. 2023. PMID: 37268451 Free PMC article.
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
Hong L, Aminu M, Li S, Lu X, Petranovic M, Saad MB, Chen P, Qin K, Varghese S, Rinsurongkawong W, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Gandhi SJ, Lin SH, Lee PP, Carter BW, Wu CC, Antonoff MB, Sepesi B, Lewis J, Gibbons DL, Vaporciyan AA, Le X, Jack Lee J, Roy-Chowdhuri S, Routbort MJ, Gainor JF, Heymach JV, Lou Y, Wu J, Zhang J, Vokes NI. Hong L, et al. Among authors: petranovic m. Nat Commun. 2023 Feb 8;14(1):695. doi: 10.1038/s41467-023-36328-z. Nat Commun. 2023. PMID: 36755027 Free PMC article.
ACR Lung-RADS v2022: Assessment Categories and Management Recommendations.
Christensen J, Prosper AE, Wu CC, Chung J, Lee E, Elicker B, Hunsaker AR, Petranovic M, Sandler KL, Stiles B, Mazzone P, Yankelevitz D, Aberle D, Chiles C, Kazerooni E. Christensen J, et al. Among authors: petranovic m. J Am Coll Radiol. 2024 Mar;21(3):473-488. doi: 10.1016/j.jacr.2023.09.009. Epub 2023 Oct 10. J Am Coll Radiol. 2024. PMID: 37820837
Mechanisms of illegitimate recombination.
Ehrlich SD, Bierne H, d'Alençon E, Vilette D, Petranovic M, Noirot P, Michel B. Ehrlich SD, et al. Among authors: petranovic m. Gene. 1993 Dec 15;135(1-2):161-6. doi: 10.1016/0378-1119(93)90061-7. Gene. 1993. PMID: 8276254 Review.
Liquid Biopsy, Diagnostic Imaging, and Future Synergies.
Petranovic M, Raoof S, Digumarthy SR, Sharma A, Shepard JO, Gainor JF, Pandharipande PV. Petranovic M, et al. J Am Coll Radiol. 2022 Feb;19(2 Pt B):336-343. doi: 10.1016/j.jacr.2021.11.001. J Am Coll Radiol. 2022. PMID: 35152958
ACR Lung-RADS v2022: Assessment Categories and Management Recommendations.
Christensen J, Prosper AE, Wu CC, Chung J, Lee E, Elicker B, Hunsaker AR, Petranovic M, Sandler KL, Stiles B, Mazzone P, Yankelevitz D, Aberle D, Chiles C, Kazerooni E. Christensen J, et al. Among authors: petranovic m. Chest. 2024 Mar;165(3):738-753. doi: 10.1016/j.chest.2023.10.028. Epub 2024 Jan 30. Chest. 2024. PMID: 38300206
74 results